PharmaLogic to acquire Lantheus CDMO business and Springfield facility
PharmaLogic announced a definitive agreement to acquire Lantheus' CDMO business and the Springfield, New Jersey manufacturing facility, expanding its U.S. radiopharmaceutical manufacturing capacity. The transaction includes a long-term supply agreement under which Agilera will manufacture lutetium Lu-177 dotatate for Lantheus.
Primary source
Company press release (PR Newswire), November 9, 2026
PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility
Read the source: PharmaLogic to Acquire Lantheus' CDMO Business and Springfield, New Jersey Manufacturing Facility prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation